Organisation paid for research Program year 2025 Source: CMS Open Payments

Alpha Oncology Research,LLC

Neither a doctor nor a teaching hospital

Research payments

$131,411

43 payments

Through program year 2025, Alpha Oncology Research,LLC is reported as receiving $131,411 in research payments, across 43 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$4,916	2
2024	Research	$24,995	6
2023	Research	$24,379	12
2022	Research	$19,098	7
2021	Research	$58,024	16

Breakdown

Who paid Research payments · program years 2021–2025

G1 Therapeutics, Inc. $101,500 35 payments
Exelixis Inc. $29,911 8 payments

Studies the money was for Research payments · program years 2021–2025

G1t28-207 $82,402 28 payments
A Phase 2/3, Randomized, Double-Blind, Controlled Study of Zanzalintinib (XL092) in Combination With Pembrolizumab vs Pembrolizumab in First-Line Treatment of Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma $29,911 8 payments
A Phase 3, Randomized, Double-Blind Study of COSELA or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE-2) $19,098 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.